Transit Officer Paul DeGeorge thought his son was lying on him. Then he realized something much scarier was happening.

A patient in the United States has become the first in the country to receive Corcym's next-generation Perceval Plus(R) LANCELOT sutureless aortic valve, marking an important milestone in the ...

The Lancelot technology delivers enhanced hemodynamics through the integration of precision laser cutting and after ...

The FDA approved the Trilogy Transcatheter Heart Valve System for the treatment of symptomatic severe aortic regurgitation, device maker JenaValve Technology announced. This approval makes Trilogy the ...

With its FDA approval, JenaValve intends to commence launch activity for the Trilogy System immediately with participating ...

The approval comes two months after Edwards Lifesciences scuttled plans to buy JenaValve for $945 million amid opposition from the Federal Trade Commission.

JenaValve announced today that it has received FDA premarket approval (PMA) for its Trilogy transcatheter heart valve system.

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket ...

I’m a 79-year-old female. Recently, I was diagnosed with moderate calcification of leaflets on my mitral valve. I have no symptoms but heard from a recent talk that even moderate calcification could ...

Novant Health has launched a robotic mitral valve repair program that is minimally invasive and has a much faster recovery time for patients needing mitral valve replacement and repair surgery. Novant ...